Expert Details

Immunology, Pre-clinical Drug Development, Inflammation, Vaccines, Infection

ID: 729263 United Kingdom

Expert trained in Immunology at the Universities of Birmingham and Bristol in the UK and became Professor of Immunology in 2005. He has particular expertise in cellular immunology, mucosal immunology and infection. He has worked widely with drug development companies and runs a CRO working on pre-clinical drug development. KWS BioTest is active in the areas of immunology, autoimmunity, inflammation, infection, pain and metabolic disease and works with pharmaceutical companies across the world to help them develop new treatments for human disease. Expert has therefore a broad understanding of pre-clinical drug development processes and in the design of packages of data to support regulatory processes.

Request Expert

Education

Year	Degree	Subject	Institution
Year: 1989	Degree: PhD	Subject: Immunology	Institution: University of Bristol
Year: 1985	Degree: BSc	Subject: Immunology and Microbiology	Institution: University of Birmingham

Work History

Years	Employer	Title	Department
Years: 2004 to Present	Employer: Undisclosed	Title: Director of Science	Department:
Responsibilities:
Years	Employer	Title	Department
Years: 1991 to Present	Employer: Undisclosed	Title: Professor of Immunology	Department:
Responsibilities:

Additional Experience

Expert Witness Experience
Patent management and proceedings at the EPO

Training / Seminars
Training in Immunology for undergraduate and post-graduate students. Training for industry staff.

Other Relevant Experience
Advisor on Immunology and pre-clinical drug development

Fields of Expertise

immune system, anti-infective agent, gram-negative bacterial infection, meningococcal infection, herpes labialis, herpes virus infection, gram-positive bacterial infection, immune disorder, immunopharmacology, ocular immunology, drug discovery, epitope, allergy, immunization, herpes simplex type 1, antiarthritis drug, interleukin, animal drug testing, pharmaceutical product development, immunosuppressive drug, immunosuppression, antiviral agent, pharmaceutical research, immunobiology, autoimmune disease, medical research, drug development, host resistance, immunocytochemistry, drug analysis, respiratory tract infection, pharmaceutical drug, enzyme-linked immunosorbent assay, cellular immunology, interferon, infectious ocular disease, cellular immunity, preventive medicine, monoclonal antibody, microbiology, influenza, infectious disease, immunotoxicology, immunology, immunoglobulin, immunoassay, drug screening, delayed-type hypersensitivity reaction, cytotoxic T lymphocyte, biomarker, bacterial disease, antibody, anti-inflammatory drug